Is asymmetric dimethylarginine a novel marker of atherosclerosis?
Böger, R.H.; Bode-Böger, S.M.; Matsuoka, H.; Miyazaki, H.; Usui, M.; Ueda, S.; Okuda, S.; Imaizumi, T.; Cooke, J.P.
Circulation 101(14): E160-E161
2000
ISSN/ISBN: 0009-7322 PMID: 10758065 Document Number: 525057
Document emailed within 1 workday
Related Documents
Sela, B.A. 2005: ADMA (asymmetric dimethylarginine)--the inhibitor of nitric oxide (NO) synthesis: a new marker for vascular pathology Harefuah 144(9): 655-659; 675, 674Cay, S.; Cagirci, G.; Akcay, M.; Karakurt, O.; Kahraman, E.; Yazihan, N.; Canga, A.; Akdemir, R.; Aydogdu, S. 2009: Asymmetric dimethylarginine levels in patients with coronary artery ectasia Kardiologia Polska 67(12): 1362-1368
Wang, D.; Lai, L.H.; Yan, P.; Dong, P.S. 2017: Correlation between blood asymmetric dimethylarginine level and the complications of patients with cardiovascular diseases Journal of Biological Regulators and Homeostatic Agents 31(1): 133-139
Namjud, N.; Chariyavilaskul, P.; Townamchai, N.; Wittayalertpanya, S. 2015: A reduction of asymmetric dimethylarginine in renal transplant recipients receiving sirolimus-based regimen Journal of the Medical Association of Thailand 98(Suppl 1): S9-13
Ludmila G. Vladimirova-Kitova; Deneva, T.I. 2010: Simvastatin and Asymmetric Dimethylarginine-Homocysteine Metabolic Pathways in Patients with Newly Detected Severe Hypercholesterolemia Clinical Laboratory 56(7-8): 291-302
Genre, F.; López-Mejías, R.; Miranda-Filloy, J.A.; Carnero-López, B.; Gómez-Acebo, I.és.; Blanco, R.; Ochoa, R.; Rueda, J.; González-Juanatey, C.; Llorca, J.; González-Gay, M.A. 2013: Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy Clinical and Experimental Rheumatology 31(5): 749-755
Calver, A.; Collier, J.; Leone, A.; Moncada, S.; Vallance, P. 1993: Effect of local intra-arterial asymmetric dimethylarginine (ADMA) on the forearm arteriolar bed of healthy volunteers Journal of Human Hypertension 7(2): 193-194
Sandoo, A.; Dimitroulas, T.; Veldhuijzen van Zanten, J.J.C.S.; Smith, J.P.; Metsios, G.S.; Nightingale, P.; Stavropoulos-Kalinoglou, A.; Kitas, G.D. 2012: Lack of association between asymmetric dimethylarginine and in vivo microvascular and macrovascular endothelial function in patients with rheumatoid arthritis Clinical and Experimental Rheumatology 30(3): 388-396
Ozgurtas, T.; Oktenli, C.; Dede, M.; Tapan, S.; Kenar, L.; Sanisoglu, S.Y.; Yesilova, Z.; Yenen, M.C.; Erbil, M.K.; Baser, I. 2008: Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS) Atherosclerosis 200(2): 336-344
Quoc Hoang, T.A.; Tam, V.; Thang, H.V. 2019: Plasma asymmetric dimethylarginine and its association with some of cardiovascular disease risk factors in chronic kidney disease Medical Journal of Malaysia 74(3): 209-214
Zsuga, J. 2008: Asymmetric dimethil-arginine (ADMA) as a link between insulin resistance and atherosclerosis Ideggyogyaszati Szemle 61(5-6): 183-192
Ezhov, M.V.; Afanas'ev, O.I.; Benevolenskaia, G.F.; Savchenko, A.P.; Liakishev, A.A.; Pokrovskiĭ, S.N. 1997: Lipoprotein(a) as a biochemical marker of coronary atherosclerosis Terapevticheskii Arkhiv 69(9): 31-34
Maldonado, J.; Galhano, E.; Almeida, L.; Pego, M.; Bastos, M.; Cabrita, S.; Ribeiro, C.A.; Wulfroth, M.; Beja, M.M.; Providência, L.A. 1994: Pulse wave velocity as initial marker of atherosclerosis Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 13(11): 845
Taute, B-M.; Taute, R.; Heins, S.; Behrmann, C.; Podhaisky, H. 2004: Hyperhomocysteinemia: marker of systemic atherosclerosis in peripheral arterial disease International Angiology: a Journal of the International Union of Angiology 23(1): 35-40
Nand, N.; Jain, R.; Seth, S.; Sen, J.; Sharma, M. 2010: A new marker of carotid atherosclerosis in middle aged adults: cystatin C or microalbuminuria Indian Heart Journal 62(4): 320-323
Mandrup-Poulsen, T.; Owerbach, D.; Johansen, K.; Nerup, J. 1985: Polymorphism of the DNA restriction fragment length flanking the insulin gene. a genetic marker for diabetic mellitus or atherosclerosis? Ugeskrift for Laeger 147(26): 2065-2071
Sergeeva, N.A.; Siniakin, K.I.; Koshkina, I.V. 2009: Lactate as a marker of ischaemia in patients with atherosclerosis obliterans of the lower limb arteries on the background of dosed physical load Angiologiia i Sosudistaia Khirurgiia 15(4): 11-13
Song, Y.; Qu, X.-f.; Yu, Y.-w.; Luan, T.-z.; Li, J.-j.; Guo, H.; Yu, Y. 2007: Relationship between plasma asymmetrical dimethylarginine and coronary artery disease Zhonghua Yi Xue Za Zhi 87(22): 1527-1530
Nimkuntod, P.; Tongdee, P. 2015: Plasma Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Concentration Ratio and Early Marker of Carotid Artery Atherosclerosis Journal of the Medical Association of Thailand 98(Suppl 4): S58-S63
Kawamura, M.; Naito, C. 1988: Progress in the study of lipoprotein metabolism and atherosclerosis: role of blood lipoproteins and pathogenesis of atherosclerosis Nihon Rinsho. Japanese Journal of Clinical Medicine 46(3): 621-628